Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales ...

Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from ...

Founded in 2012, 10x Genomics (NASDAQ:TXG) develops single-cell and spatial genomics solutions, enabling researchers to analyze biological systems at high resolution. Genomics and sequencing ...

Coupled with the invalidation of 10x Genomics’ 10,155,981 patent last ... differentiated solution that makes single cell sequencing more scalable without the need for expensive microfluidics.

10x Genomics, Inc. (NASDAQ:TXG), a biotechnology company based in California, develops gene sequencing technology for scientific research. The company sells a variety of items, including reagent ...

Sequencing will be performed on the UG 100 ... chan-zuckerberg-initiative-launches-billion-cells-project-with-10x-genomics-and-ultima-genomics-to-advance-ai-in-biology-302369647.html Smart ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...